Is Neoadjuvant Chemoradiotherapy Beneficial for Patients With Pancreatic Cancer?

Pawel Mroczkowski1, Radoslaw Zajdel1

  • 1Pawel Mroczkowski, MD, PhD, Department of Surgery, University Hospital Knappschaftskrankenhaus Bochum, Ruhr-University-Bochum, Bochum, Germany, An-Istitut for Quality Assurance in the Operative Medicine Ltd, Otto-von-Guericke-University-Magdeburg, Magdeburg, Germany, Department for General and Colorectal Surgery, Medical University of Łódź, Lodz, Poland; and Radoslaw Zajdel, Department of Medical Informatics and Statistics, Medical University of Łódź, Lodz, Poland.

Abstract

No abstract available in PubMed .